35 related articles for article (PubMed ID: 8118325)
21. DNA flow cytometric measurements in breast cancer: a review of the instrumentation principles and clinical significance.
Berho M; Viciana AL; Poppiti RJ; Ruiz P
J Fla Med Assoc; 1997 Feb; 84(2):104-10. PubMed ID: 9066236
[TBL] [Abstract][Full Text] [Related]
22. [DNA cytometry in breast carcinoma. Review of method and value in assessing prognosis].
Sinn HP; Haag D; Ehemann V; Magener A; Goerttler K; Bastert G; Otto HF
Pathologe; 1997 Jan; 18(1):19-26. PubMed ID: 9157400
[TBL] [Abstract][Full Text] [Related]
23. Ploidy and proliferation rates in carcinomas of the breast in Tanzania.
Kitinya JN; Mbonde MP; Guthe HJ; Akslen LA
East Afr Med J; 1994 Mar; 71(3):195-8. PubMed ID: 7956869
[TBL] [Abstract][Full Text] [Related]
24. DNA ploidy and cell cycle analysis in breast cancer.
Ross JS; Linette GP; Stec J; Ross MS; Anwar S; Boguniewicz A
Am J Clin Pathol; 2003 Dec; 120 Suppl():S72-84. PubMed ID: 15298145
[TBL] [Abstract][Full Text] [Related]
25. DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast.
Hedley DW; Clark GM; Cornelisse CJ; Killander D; Kute T; Merkel D
Breast Cancer Res Treat; 1993 Oct; 28(1):55-9. PubMed ID: 8123870
[TBL] [Abstract][Full Text] [Related]
26. DNA ploidy and S-phase fraction as prognostic factors in cervical cancer.
Rothenberg ML
Cancer Treat Res; 1994; 70():53-62. PubMed ID: 8060751
[No Abstract] [Full Text] [Related]
27. Is DNA flow cytometry a useful investigation in breast cancer?
O'Reilly SM; Richards MA
Eur J Cancer; 1992; 28(2-3):504-7. PubMed ID: 1591074
[No Abstract] [Full Text] [Related]
28. Usefulness of flow cytometric DNA measurements in genital and breast cancers.
Trope C; Lindahl B; Kaern J; Iversen OE
Eur J Gynaecol Oncol; 1989; 10(3):191-5. PubMed ID: 2659366
[No Abstract] [Full Text] [Related]
29. DNA cytometry consensus conference.
Hedley DW; Shankey TV; Wheeless LL
Cytometry; 1993; 14(5):471. PubMed ID: 8354116
[No Abstract] [Full Text] [Related]
30. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.
Altman DG; Lausen B; Sauerbrei W; Schumacher M
J Natl Cancer Inst; 1994 Jun; 86(11):829-35. PubMed ID: 8182763
[No Abstract] [Full Text] [Related]
31. [DNA flow cytometric analysis in primary breast cancer. S-phase and ploidy status as prognostic factors and their correlation to tumor-associated proteolytic factors].
Harbeck N; Schüren E; Yamamoto N; Pache L; Schmitt M; Jänicke F; Dettmar P; Höfler H; Graeff H
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():303-4. PubMed ID: 8118325
[No Abstract] [Full Text] [Related]
32. [DNA ploidy pattern, S-phase fraction as a prognostic factor of breast cancers].
Kimijima I; Katagata N; Tsuchiya A; Takenoshita S
Nihon Rinsho; 2000 Apr; 58 Suppl():401-6. PubMed ID: 11026024
[No Abstract] [Full Text] [Related]
33. [Flow cytometric analysis of DNA ploidy pattern in breast cancer: malignant potential and prognostic implication].
Hara S; Tomita M
Nihon Rinsho; 1992 Oct; 50(10):2444-9. PubMed ID: 1447815
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer.
Batsakis JG; Sneige N; el-Naggar AK
Cancer; 1993 Mar; 71(6 Suppl):2151-3. PubMed ID: 8443764
[TBL] [Abstract][Full Text] [Related]
35. [tPA, uPA, PAI-1 as prognostic factors of breast cancers].
Shiba E; Kim SJ
Nihon Rinsho; 2000 Apr; 58 Suppl():429-34. PubMed ID: 11026029
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
